P06.06 Is activating transcription factor 5 (ATF5) a new therapeutic target in astrocytomas of different WHO grades and varying biological behavior? An expression analysis

Jonas Feldheim*

*Corresponding author for this work

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish
DOIs
Publication statusPublished - Oct 2016
Externally publishedYes

Cite this